Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
24
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Wyman Lisa | Director | 2 | $0 | $0 | 2026-06-18 |
| Mayer Howard | Director | 4 | $0 | $0 | 2026-06-18 |
| Resnick Joshua | Director | 5 | $0 | $0 | 2026-06-18 |
| Dable Habib J | Director | 5 | $0 | $0 | 2026-06-18 |
| KEATING LAURIE | Director | 6 | $50.0K | $0 | 2026-06-18 |
| Finer Mitchell H. | Director | 2 | $0 | $0 | 2026-06-18 |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | 1 | $0 | $0 | 2026-06-18 |
| HENSON HEIDI | Director | 5 | $0 | $0 | 2026-06-18 |
| Kasraian Kasra | Chief Technical Officer | 5 | $0 | $1.7K | 2026-05-21 |
| Donnelly Noel | Chief Financial Officer | 19 | $0 | $15.6K | 2026-03-04 |
| McArthur James G | President and CEO | 41 | $68.4K | $538.3K | 2026-03-04 |
| STRECK PAUL | EVP, Head of R&D | 13 | $10.4K | $11.7K | 2026-03-04 |
| Vittiglio Joseph | Chief Business & Legal Officer | 4 | $0 | $0 | 2026-03-01 |
| Oxford Science Enterprises plc | Other | 8 | $11.20M | $0 | 2025-09-30 |
| RA Capital Healthcare Fund LP | Director, 10% Owner | 1 | $30.00M | $0 | 2025-09-26 |
| Kolchinsky Peter | Director, 10% Owner | 13 | $65.96M | $0 | 2025-06-04 |
| DeLena Mary Beth | General Counsel | 5 | $0 | $2.4K | 2025-03-03 |
| Mellion Michelle L | See Remarks | 41 | $0 | $905.6K | 2024-07-25 |
| Ashton Christopher | Director | 3 | $0 | $0 | 2024-06-20 |
| RA Capital Nexus Fund II, L.P. | Director | 1 | $0 | $0 | 2024-06-20 |
| Svenstrup Niels | See Remarks | 6 | $0 | $134.1K | 2024-05-17 |
| Goyal Jaya | See Remarks | 14 | $0 | $110.6K | 2023-03-24 |
| Deerfield Private Design Fund V, L.P. | 10% Owner | 6 | $5.00M | $0 | 2022-05-10 |
| Bracegirdle Sonia | See Remarks | 1 | $0 | $0 | 2022-05-06 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| KEATING LAURIE | Director | A Award deriv | 2026-06-18 | 2026-06-22 | 34,000 | — | $0 | 34,000 | SEC↗ |
| HENSON HEIDI | Director | A Award deriv | 2026-06-18 | 2026-06-22 | 34,000 | — | $0 | 34,000 | SEC↗ |
| Dable Habib J | Director | A Award deriv | 2026-06-18 | 2026-06-22 | 34,000 | — | $0 | 34,000 | SEC↗ |
| Finer Mitchell H. | Director | A Award deriv | 2026-06-18 | 2026-06-22 | 34,000 | — | $0 | 34,000 | SEC↗ |
| Mayer Howard | Director | A Award deriv | 2026-06-18 | 2026-06-22 | 34,000 | — | $0 | 34,000 | SEC↗ |
| Resnick Joshua | Director | A Award deriv | 2026-06-18 | 2026-06-22 | 34,000 | — | $0 | 34,000 | SEC↗ |
| Wyman Lisa | Director | A Award deriv | 2026-06-18 | 2026-06-22 | 34,000 | — | $0 | 34,000 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | A Award deriv | 2026-06-18 | 2026-06-22 | 34,000 | — | $0 | 34,000 | SEC↗ |
| Kasraian Kasra | Chief Technical Officer | S Sale | 2026-05-21 | 2026-05-26 | 1,233 | $1.41 | $1.7K | 50,074 | SEC↗ |
| McArthur James G | President and CEO | S Sale | 2026-03-04 | 2026-03-06 | 5,144 | $6.23 | $32.0K | 296,457 | SEC↗ |
| McArthur James G | President and CEO | S Sale | 2026-03-04 | 2026-03-06 | 131 | $6.33 | $829 | 296,326 | SEC↗ |
| Donnelly Noel | Chief Financial Officer | S Sale | 2026-03-04 | 2026-03-06 | 52 | $6.33 | $329 | 111,603 | SEC↗ |
| Donnelly Noel | Chief Financial Officer | S Sale | 2026-03-04 | 2026-03-06 | 2,032 | $6.23 | $12.7K | 111,655 | SEC↗ |
| STRECK PAUL | EVP, Head of R&D | S Sale | 2026-03-04 | 2026-03-06 | 47 | $6.29 | $296 | 76,226 | SEC↗ |
| STRECK PAUL | EVP, Head of R&D | S Sale | 2026-03-04 | 2026-03-06 | 1,832 | $6.23 | $11.4K | 76,273 | SEC↗ |
| McArthur James G | President and CEO | A Award deriv | 2026-03-01 | 2026-03-02 | 731,250 | — | $0 | 731,250 | SEC↗ |
| Donnelly Noel | Chief Financial Officer | A Award deriv | 2026-03-01 | 2026-03-02 | 300,000 | — | $0 | 300,000 | SEC↗ |
| STRECK PAUL | EVP, Head of R&D | A Award deriv | 2026-03-01 | 2026-03-02 | 196,500 | — | $0 | 196,500 | SEC↗ |
| Kasraian Kasra | Chief Technical Officer | A Award deriv | 2026-03-01 | 2026-03-02 | 135,000 | — | $0 | 135,000 | SEC↗ |
| Vittiglio Joseph | Chief Business & Legal Offic | A Award deriv | 2026-03-01 | 2026-03-02 | 120,000 | — | $0 | 120,000 | SEC↗ |
| McArthur James G | President and CEO | A Award | 2026-03-01 | 2026-03-02 | 187,688 | — | $0 | 301,601 | SEC↗ |
| Donnelly Noel | Chief Financial Officer | A Award | 2026-03-01 | 2026-03-02 | 76,793 | — | $0 | 113,687 | SEC↗ |
| STRECK PAUL | EVP, Head of R&D | A Award | 2026-03-01 | 2026-03-02 | 50,300 | — | $0 | 78,105 | SEC↗ |
| Kasraian Kasra | Chief Technical Officer | A Award | 2026-03-01 | 2026-03-02 | 34,557 | — | $0 | 51,307 | SEC↗ |
| Vittiglio Joseph | Chief Business & Legal Offic | A Award | 2026-03-01 | 2026-03-02 | 30,717 | — | $0 | 65,717 | SEC↗ |
| Vittiglio Joseph | Chief Business & Legal Offic | A Award deriv | 2025-12-08 | 2025-12-10 | 160,000 | — | $0 | 160,000 | SEC↗ |
| Vittiglio Joseph | Chief Business & Legal Offic | A Award | 2025-12-08 | 2025-12-10 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Donnelly Noel | Chief Financial Officer | D To issuer deriv | 2025-11-04 | 2025-12-18 | 169,037 | — | $0 | 0 | SEC↗ |
| Donnelly Noel | Chief Financial Officer | A Award deriv | 2025-11-04 | 2025-12-18 | 169,037 | — | $0 | 169,037 | SEC↗ |
| Donnelly Noel | Chief Financial Officer | D To issuer deriv | 2025-11-04 | 2025-12-18 | 144,000 | — | $0 | 0 | SEC↗ |
| Donnelly Noel | Chief Financial Officer | A Award deriv | 2025-11-04 | 2025-12-18 | 144,000 | — | $0 | 144,000 | SEC↗ |
| Donnelly Noel | Chief Financial Officer | D To issuer deriv | 2025-11-04 | 2025-12-18 | 144,000 | — | $0 | 0 | SEC↗ |
| Donnelly Noel | Chief Financial Officer | A Award deriv | 2025-11-04 | 2025-12-18 | 144,000 | — | $0 | 144,000 | SEC↗ |
| Donnelly Noel | Chief Financial Officer | D To issuer deriv | 2025-11-04 | 2025-12-18 | 203,339 | — | $0 | 0 | SEC↗ |
| Donnelly Noel | Chief Financial Officer | A Award deriv | 2025-11-04 | 2025-12-18 | 203,339 | — | $0 | 203,339 | SEC↗ |
| McArthur James G | President and CEO | D To issuer deriv | 2025-11-04 | 2025-12-18 | 466,095 | — | $0 | 0 | SEC↗ |
| McArthur James G | President and CEO | A Award deriv | 2025-11-04 | 2025-12-18 | 40,815 | — | $0 | 40,815 | SEC↗ |
| McArthur James G | President and CEO | D To issuer deriv | 2025-11-04 | 2025-12-18 | 275,000 | — | $0 | 0 | SEC↗ |
| McArthur James G | President and CEO | A Award deriv | 2025-11-04 | 2025-12-18 | 275,000 | — | $0 | 275,000 | SEC↗ |
| McArthur James G | President and CEO | D To issuer deriv | 2025-11-04 | 2025-12-18 | 300,000 | — | $0 | 0 | SEC↗ |
| McArthur James G | President and CEO | A Award deriv | 2025-11-04 | 2025-12-18 | 300,000 | — | $0 | 300,000 | SEC↗ |
| McArthur James G | President and CEO | D To issuer deriv | 2025-11-04 | 2025-12-18 | 352,705 | — | $0 | 0 | SEC↗ |
| McArthur James G | President and CEO | A Award deriv | 2025-11-04 | 2025-12-18 | 352,705 | — | $0 | 352,705 | SEC↗ |
| McArthur James G | President and CEO | D To issuer deriv | 2025-11-04 | 2025-12-18 | 40,815 | — | $0 | 0 | SEC↗ |
| McArthur James G | President and CEO | A Award deriv | 2025-11-04 | 2025-12-18 | 40,815 | — | $0 | 40,815 | SEC↗ |
| McArthur James G | President and CEO | D To issuer deriv | 2025-11-04 | 2025-12-18 | 40,815 | — | $0 | 0 | SEC↗ |
| McArthur James G | President and CEO | A Award deriv | 2025-11-04 | 2025-12-18 | 40,815 | — | $0 | 40,815 | SEC↗ |
| McArthur James G | President and CEO | D To issuer deriv | 2025-11-04 | 2025-12-18 | 40,815 | — | $0 | 0 | SEC↗ |
| McArthur James G | President and CEO | A Award deriv | 2025-11-04 | 2025-12-18 | 466,095 | — | $0 | 466,095 | SEC↗ |
| STRECK PAUL | EVP, Head of R&D | D To issuer deriv | 2025-11-04 | 2025-12-18 | 40,000 | — | $0 | 0 | SEC↗ |
| STRECK PAUL | EVP, Head of R&D | A Award deriv | 2025-11-04 | 2025-12-18 | 40,000 | — | $0 | 242,816 | SEC↗ |
| STRECK PAUL | EVP, Head of R&D | D To issuer deriv | 2025-11-04 | 2025-12-18 | 202,816 | — | $0 | 40,000 | SEC↗ |
| STRECK PAUL | EVP, Head of R&D | A Award deriv | 2025-11-04 | 2025-12-18 | 202,816 | — | $0 | 202,816 | SEC↗ |
| Oxford Science Enterprises plc | Other | P Buy | 2025-09-30 | 2025-10-01 | 200,000 | $3.20 | $640.0K | 4,955,388 | SEC↗ |
| RA Capital Healthcare Fund LP | Director, 10% Owner | P Buy | 2025-09-26 | 2025-09-30 | 9,375,000 | $3.20 | $30.00M | 18,554,273 | SEC↗ |
| Resnick Joshua | Director | A Award deriv | 2025-06-04 | 2025-06-06 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Dable Habib J | Director | A Award deriv | 2025-06-04 | 2025-06-06 | 16,000 | — | $0 | 16,000 | SEC↗ |
| KEATING LAURIE | Director | A Award deriv | 2025-06-04 | 2025-06-06 | 16,000 | — | $0 | 16,000 | SEC↗ |
| HENSON HEIDI | Director | A Award deriv | 2025-06-04 | 2025-06-06 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Mayer Howard | Director | A Award deriv | 2025-06-04 | 2025-06-06 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | A Award deriv | 2025-06-04 | 2025-06-06 | 16,000 | — | $0 | 16,000 | SEC↗ |
| STRECK PAUL | EVP, Head of R&D | P Buy | 2025-05-30 | 2025-06-02 | 8,375 | $1.24 | $10.4K | 27,805 | SEC↗ |
| Kasraian Kasra | Chief Technical Officer | A Award deriv | 2025-05-20 | 2025-05-21 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Kasraian Kasra | Chief Technical Officer | A Award | 2025-05-20 | 2025-05-21 | 16,750 | — | $0 | 16,750 | SEC↗ |
| McArthur James G | President and CEO | P Buy | 2025-04-17 | 2025-04-22 | 10,000 | $1.36 | $13.6K | 113,913 | SEC↗ |
| McArthur James G | President and CEO | P Buy | 2025-04-08 | 2025-04-09 | 41,500 | $1.15 | $47.7K | 103,913 | SEC↗ |
| Wyman Lisa | Director | A Award deriv | 2025-03-27 | 2025-03-31 | 26,000 | — | $0 | 26,000 | SEC↗ |
| Finer Mitchell H. | Director | A Award deriv | 2025-03-27 | 2025-03-31 | 26,000 | — | $0 | 26,000 | SEC↗ |
| McArthur James G | President and CEO | A Award deriv | 2025-03-03 | 2025-03-05 | 271,875 | — | $0 | 271,875 | SEC↗ |
| STRECK PAUL | EVP, Head of R&D | A Award deriv | 2025-03-03 | 2025-03-05 | 87,000 | — | $0 | 87,000 | SEC↗ |
| Donnelly Noel | Chief Financial Officer | A Award deriv | 2025-03-03 | 2025-03-05 | 104,250 | — | $0 | 104,250 | SEC↗ |
| DeLena Mary Beth | General Counsel | A Award deriv | 2025-03-03 | 2025-03-05 | 60,000 | — | $0 | 60,000 | SEC↗ |
| McArthur James G | President and CEO | A Award | 2025-03-03 | 2025-03-05 | 60,719 | — | $0 | 62,413 | SEC↗ |
| STRECK PAUL | EVP, Head of R&D | A Award | 2025-03-03 | 2025-03-05 | 19,430 | — | $0 | 19,430 | SEC↗ |
| Donnelly Noel | Chief Financial Officer | A Award | 2025-03-03 | 2025-03-05 | 23,283 | — | $0 | 24,956 | SEC↗ |
| DeLena Mary Beth | General Counsel | A Award | 2025-03-03 | 2025-03-05 | 13,400 | — | $0 | 14,968 | SEC↗ |
| Donnelly Noel | Chief Financial Officer | S Sale | 2025-02-26 | 2025-02-26 | 1,527 | $1.68 | $2.6K | 1,673 | SEC↗ |
| DeLena Mary Beth | General Counsel | S Sale | 2025-02-26 | 2025-02-26 | 1,432 | $1.68 | $2.4K | 1,568 | SEC↗ |
| Donnelly Noel | Chief Financial Officer | A Award | 2025-02-24 | 2025-02-26 | 3,200 | — | $0 | 3,200 | SEC↗ |
| DeLena Mary Beth | General Counsel | A Award | 2025-02-24 | 2025-02-26 | 3,000 | — | $0 | 3,000 | SEC↗ |
| STRECK PAUL | EVP, Head of R&D | A Award deriv | 2024-08-19 | 2024-08-20 | 40,000 | — | $0 | 242,816 | SEC↗ |
| STRECK PAUL | EVP, Head of R&D | A Award deriv | 2024-08-19 | 2024-08-20 | 202,816 | — | $0 | 202,816 | SEC↗ |
| Mellion Michelle L | Chief Medical Officer | M Exercise deriv | 2024-07-25 | 2024-07-26 | 7,571 | — | $0 | 50,000 | SEC↗ |
| Mellion Michelle L | Chief Medical Officer | S Sale | 2024-07-25 | 2024-07-26 | 7,571 | $18.06 | $136.7K | 0 | SEC↗ |
| Mellion Michelle L | Chief Medical Officer | M Exercise | 2024-07-25 | 2024-07-26 | 7,571 | $10.21 | $77.3K | 7,571 | SEC↗ |
| Mellion Michelle L | Chief Medical Officer | M Exercise deriv | 2024-07-24 | 2024-07-26 | 201 | — | $0 | 57,571 | SEC↗ |
| Mellion Michelle L | Chief Medical Officer | S Sale | 2024-07-24 | 2024-07-26 | 201 | $18.01 | $3.6K | 0 | SEC↗ |
| Mellion Michelle L | Chief Medical Officer | M Exercise | 2024-07-24 | 2024-07-26 | 201 | $10.21 | $2.1K | 201 | SEC↗ |
| Mellion Michelle L | Chief Medical Officer | M Exercise deriv | 2024-07-18 | 2024-07-19 | 12,625 | — | $0 | 57,772 | SEC↗ |
| Mellion Michelle L | Chief Medical Officer | M Exercise | 2024-07-18 | 2024-07-19 | 12,625 | $10.21 | $128.9K | 12,625 | SEC↗ |
| Mellion Michelle L | Chief Medical Officer | S Sale | 2024-07-18 | 2024-07-19 | 12,625 | $18.20 | $229.8K | 0 | SEC↗ |
| Mellion Michelle L | Chief Medical Officer | M Exercise deriv | 2024-07-16 | 2024-07-16 | 5,901 | — | $0 | 70,397 | SEC↗ |
| Mellion Michelle L | Chief Medical Officer | S Sale | 2024-07-16 | 2024-07-16 | 5,901 | $18.00 | $106.2K | 0 | SEC↗ |
| Mellion Michelle L | Chief Medical Officer | M Exercise | 2024-07-16 | 2024-07-16 | 5,901 | $10.21 | $60.2K | 5,901 | SEC↗ |
| Mellion Michelle L | Chief Medical Officer | M Exercise deriv | 2024-07-12 | 2024-07-16 | 3,288 | — | $0 | 76,298 | SEC↗ |
| Mellion Michelle L | Chief Medical Officer | S Sale | 2024-07-12 | 2024-07-16 | 3,288 | $18.04 | $59.3K | 0 | SEC↗ |
| Mellion Michelle L | Chief Medical Officer | M Exercise | 2024-07-12 | 2024-07-16 | 3,288 | $10.21 | $33.6K | 3,288 | SEC↗ |
| Mellion Michelle L | Chief Medical Officer | M Exercise deriv | 2024-07-02 | 2024-07-03 | 37 | — | $0 | 79,586 | SEC↗ |
| Mellion Michelle L | Chief Medical Officer | M Exercise | 2024-07-02 | 2024-07-03 | 37 | $10.21 | $378 | 37 | SEC↗ |
| Mellion Michelle L | Chief Medical Officer | S Sale | 2024-07-02 | 2024-07-03 | 37 | $18.07 | $669 | 0 | SEC↗ |
| Mellion Michelle L | Chief Medical Officer | M Exercise deriv | 2024-07-01 | 2024-07-03 | 875 | — | $0 | 79,623 | SEC↗ |
| Mellion Michelle L | Chief Medical Officer | M Exercise | 2024-07-01 | 2024-07-03 | 875 | $10.21 | $8.9K | 875 | SEC↗ |
| Mellion Michelle L | Chief Medical Officer | S Sale | 2024-07-01 | 2024-07-03 | 875 | $18.01 | $15.8K | 0 | SEC↗ |
| Mellion Michelle L | Chief Medical Officer | M Exercise deriv | 2024-06-24 | 2024-06-26 | 9,260 | — | $0 | 80,498 | SEC↗ |
| Mellion Michelle L | Chief Medical Officer | M Exercise | 2024-06-24 | 2024-06-26 | 9,260 | $10.21 | $94.5K | 9,260 | SEC↗ |
| Mellion Michelle L | Chief Medical Officer | S Sale | 2024-06-24 | 2024-06-26 | 9,260 | $18.19 | $168.4K | 0 | SEC↗ |
| Dable Habib J | Director | A Award deriv | 2024-06-20 | 2024-06-21 | 13,000 | — | $0 | 13,000 | SEC↗ |
| Mayer Howard | Director | A Award deriv | 2024-06-20 | 2024-06-21 | 8,667 | — | $0 | 8,667 | SEC↗ |
| Ashton Christopher | Director | A Award deriv | 2024-06-20 | 2024-06-21 | 13,000 | — | $0 | 13,000 | SEC↗ |
| Resnick Joshua | Director | A Award deriv | 2024-06-20 | 2024-06-21 | 13,000 | — | $0 | 13,000 | SEC↗ |
| KEATING LAURIE | Director | A Award deriv | 2024-06-20 | 2024-06-21 | 13,000 | — | $0 | 13,000 | SEC↗ |
| HENSON HEIDI | Director | A Award deriv | 2024-06-20 | 2024-06-21 | 13,000 | — | $0 | 13,000 | SEC↗ |
| RA Capital Nexus Fund II, L.P. | Director | A Award deriv | 2024-06-20 | 2024-06-21 | 13,000 | — | $0 | 13,000 | SEC↗ |
| Mellion Michelle L | Chief Medical Officer | M Exercise deriv | 2024-06-12 | 2024-06-13 | 1,086 | — | $0 | 89,758 | SEC↗ |
| Mellion Michelle L | Chief Medical Officer | M Exercise | 2024-06-12 | 2024-06-13 | 1,086 | $10.21 | $11.1K | 1,086 | SEC↗ |
| Mellion Michelle L | Chief Medical Officer | S Sale | 2024-06-12 | 2024-06-13 | 1,086 | $18.06 | $19.6K | 0 | SEC↗ |
| Mellion Michelle L | Chief Medical Officer | M Exercise deriv | 2024-06-11 | 2024-06-13 | 500 | — | $0 | 90,844 | SEC↗ |
| Mellion Michelle L | Chief Medical Officer | M Exercise | 2024-06-11 | 2024-06-13 | 500 | $10.21 | $5.1K | 500 | SEC↗ |
| Mellion Michelle L | Chief Medical Officer | S Sale | 2024-06-11 | 2024-06-13 | 500 | $18.04 | $9.0K | 0 | SEC↗ |
| Mellion Michelle L | SVP, Clinical Development | M Exercise deriv | 2024-06-06 | 2024-06-07 | 1,411 | — | $0 | 91,344 | SEC↗ |
| Mellion Michelle L | SVP, Clinical Development | S Sale | 2024-06-06 | 2024-06-07 | 1,411 | $18.00 | $25.4K | 0 | SEC↗ |
| Mellion Michelle L | SVP, Clinical Development | M Exercise | 2024-06-06 | 2024-06-07 | 1,411 | $10.21 | $14.4K | 1,411 | SEC↗ |
| Mellion Michelle L | SVP, Clinical Development | M Exercise deriv | 2024-06-05 | 2024-06-07 | 7,245 | — | $0 | 92,755 | SEC↗ |
| Mellion Michelle L | SVP, Clinical Development | M Exercise | 2024-06-05 | 2024-06-07 | 7,245 | $10.21 | $74.0K | 7,245 | SEC↗ |
| Mellion Michelle L | SVP, Clinical Development | S Sale | 2024-06-05 | 2024-06-07 | 7,245 | $18.09 | $131.1K | 0 | SEC↗ |
| Svenstrup Niels | SVP, Chem. Mfg & Controls | S Sale | 2024-05-17 | 2024-05-17 | 10,000 | $13.41 | $134.1K | 0 | SEC↗ |
| Mellion Michelle L | SVP, Clinical Development | A Award deriv | 2024-03-01 | 2024-03-01 | 83,000 | — | $0 | 83,000 | SEC↗ |
| Donnelly Noel | Chief Financial Officer | A Award deriv | 2024-03-01 | 2024-03-01 | 144,000 | — | $0 | 144,000 | SEC↗ |
| McArthur James G | President and CEO | A Award deriv | 2024-03-01 | 2024-03-01 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Svenstrup Niels | SVP, Chem. Mfg & Controls | A Award deriv | 2024-03-01 | 2024-03-01 | 83,000 | — | $0 | 83,000 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | P Buy | 2024-02-09 | 2024-02-13 | 2,557,593 | $10.64 | $27.21M | 9,179,273 | SEC↗ |
| DeLena Mary Beth | General Counsel | A Award deriv | 2024-01-15 | 2024-01-17 | 125,000 | — | $0 | 125,000 | SEC↗ |
| McArthur James G | President and CEO | P Buy | 2023-11-30 | 2023-12-05 | 1,694 | $4.17 | $7.1K | 1,694 | SEC↗ |
| Mayer Howard | Director | A Award deriv | 2023-11-10 | 2023-11-14 | 22,686 | — | $0 | 22,686 | SEC↗ |
| Dable Habib J | Director | A Award deriv | 2023-06-22 | 2023-06-26 | 9,000 | — | $0 | 9,000 | SEC↗ |
| HENSON HEIDI | Director | A Award deriv | 2023-06-22 | 2023-06-26 | 12,000 | — | $0 | 12,000 | SEC↗ |
| KEATING LAURIE | Director | A Award deriv | 2023-06-22 | 2023-06-26 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Resnick Joshua | Director | A Award deriv | 2023-06-22 | 2023-06-26 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Ashton Christopher | Director | A Award deriv | 2023-06-22 | 2023-06-26 | 12,000 | — | $0 | 12,000 | SEC↗ |
| McArthur James G | President and CEO | M Exercise deriv | 2023-06-08 | 2023-06-09 | 2,381 | — | $0 | 325,054 | SEC↗ |
| McArthur James G | President and CEO | S Sale | 2023-06-08 | 2023-06-09 | 2,381 | $16.04 | $38.2K | 0 | SEC↗ |
| McArthur James G | President and CEO | M Exercise | 2023-06-08 | 2023-06-09 | 2,381 | $2.71 | $6.5K | 2,381 | SEC↗ |
| McArthur James G | President and CEO | M Exercise deriv | 2023-06-07 | 2023-06-08 | 8,419 | — | $0 | 327,435 | SEC↗ |
| McArthur James G | President and CEO | S Sale | 2023-06-07 | 2023-06-08 | 8,419 | $16.23 | $136.6K | 0 | SEC↗ |
| McArthur James G | President and CEO | M Exercise | 2023-06-07 | 2023-06-08 | 8,419 | $2.71 | $22.8K | 8,419 | SEC↗ |
| McArthur James G | President and CEO | M Exercise deriv | 2023-06-06 | 2023-06-08 | 18,150 | — | $0 | 335,854 | SEC↗ |
| McArthur James G | President and CEO | S Sale | 2023-06-06 | 2023-06-08 | 18,150 | $16.18 | $293.7K | 0 | SEC↗ |
| McArthur James G | President and CEO | M Exercise | 2023-06-06 | 2023-06-08 | 18,150 | $2.71 | $49.2K | 18,150 | SEC↗ |
| McArthur James G | President and CEO | M Exercise deriv | 2023-06-05 | 2023-06-06 | 500 | — | $0 | 354,004 | SEC↗ |
| McArthur James G | President and CEO | M Exercise | 2023-06-05 | 2023-06-06 | 500 | $2.71 | $1.4K | 500 | SEC↗ |
| McArthur James G | President and CEO | S Sale | 2023-06-05 | 2023-06-06 | 500 | $16.06 | $8.0K | 0 | SEC↗ |
| McArthur James G | President and CEO | M Exercise deriv | 2023-06-02 | 2023-06-06 | 1,800 | — | $0 | 354,504 | SEC↗ |
| McArthur James G | President and CEO | S Sale | 2023-06-02 | 2023-06-06 | 1,800 | $16.04 | $28.9K | 0 | SEC↗ |
| McArthur James G | President and CEO | M Exercise | 2023-06-02 | 2023-06-06 | 1,800 | $2.71 | $4.9K | 1,800 | SEC↗ |
| Goyal Jaya | EVP, Res. & Preclin. Dev. | M Exercise deriv | 2023-03-24 | 2023-03-28 | 392 | — | $0 | 143,804 | SEC↗ |
| Goyal Jaya | EVP, Res. & Preclin. Dev. | S Sale | 2023-03-24 | 2023-03-28 | 392 | $20.00 | $7.8K | 0 | SEC↗ |
| Goyal Jaya | EVP, Res. & Preclin. Dev. | M Exercise | 2023-03-24 | 2023-03-28 | 392 | $10.88 | $4.3K | 392 | SEC↗ |
| Donnelly Noel | Chief Financial Officer | A Award deriv | 2023-03-01 | 2023-03-02 | 144,000 | — | $0 | 144,000 | SEC↗ |
| McArthur James G | President and CEO | A Award deriv | 2023-03-01 | 2023-03-02 | 275,000 | — | $0 | 275,000 | SEC↗ |
| Svenstrup Niels | SVP, Chem. Mfg & Controls | A Award deriv | 2023-03-01 | 2023-03-02 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Goyal Jaya | EVP, Res. & Preclin. Dev. | A Award deriv | 2023-03-01 | 2023-03-02 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Mellion Michelle L | SVP, Clinical Development | A Award deriv | 2023-03-01 | 2023-03-02 | 20,000 | — | $0 | 95,000 | SEC↗ |
| Mellion Michelle L | SVP, Clinical Development | A Award deriv | 2023-03-01 | 2023-03-02 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Goyal Jaya | EVP, Res. & Preclin. Dev. | M Exercise deriv | 2023-02-08 | 2023-02-08 | 644 | — | $0 | 144,196 | SEC↗ |
| Goyal Jaya | EVP, Res. & Preclin. Dev. | M Exercise | 2023-02-08 | 2023-02-08 | 644 | $10.88 | $7.0K | 644 | SEC↗ |
| Goyal Jaya | EVP, Res. & Preclin. Dev. | S Sale | 2023-02-08 | 2023-02-08 | 644 | $17.00 | $10.9K | 0 | SEC↗ |
| Goyal Jaya | EVP, Res. & Preclin. Dev. | M Exercise deriv | 2023-02-07 | 2023-02-08 | 3,679 | — | $0 | 144,840 | SEC↗ |
| Goyal Jaya | EVP, Res. & Preclin. Dev. | M Exercise | 2023-02-07 | 2023-02-08 | 3,679 | $10.88 | $40.0K | 3,679 | SEC↗ |
| Goyal Jaya | EVP, Res. & Preclin. Dev. | S Sale | 2023-02-07 | 2023-02-08 | 3,679 | $17.18 | $63.2K | 0 | SEC↗ |
| Goyal Jaya | EVP, Res. & Preclin. Dev. | M Exercise deriv | 2023-02-06 | 2023-02-08 | 1,677 | — | $0 | 148,519 | SEC↗ |
| Goyal Jaya | EVP, Res. & Preclin. Dev. | S Sale | 2023-02-06 | 2023-02-08 | 1,677 | $17.04 | $28.6K | 0 | SEC↗ |
| Goyal Jaya | EVP, Res. & Preclin. Dev. | M Exercise | 2023-02-06 | 2023-02-08 | 1,677 | $10.88 | $18.2K | 1,677 | SEC↗ |
| Svenstrup Niels | SVP, Chem. Mfg & Controls | M Exercise deriv | 2022-12-19 | 2022-12-19 | 10,000 | — | $0 | 25,629 | SEC↗ |
| Svenstrup Niels | SVP, Chem. Mfg & Controls | M Exercise | 2022-12-19 | 2022-12-19 | 10,000 | $2.71 | $27.1K | 10,000 | SEC↗ |
| Dable Habib J | Director | A Award deriv | 2022-10-03 | 2022-10-03 | 22,686 | — | $0 | 22,686 | SEC↗ |
| Mellion Michelle L | See Remarks | A Award deriv | 2022-07-01 | 2022-08-31 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Oxford Science Enterprises plc | 10% Owner | P Buy | 2022-05-10 | 2024-04-09 | 879,970 | $12.00 | $10.56M | 4,755,388 | SEC↗ |
| Deerfield Private Design Fund | 10% Owner | C Conversion deriv | 2022-05-10 | 2022-05-10 | 273,313 | — | $0 | 0 | SEC↗ |
| Deerfield Private Design Fund | 10% Owner | C Conversion deriv | 2022-05-10 | 2022-05-10 | 273,313 | — | $0 | 0 | SEC↗ |
| Oxford Science Enterprises plc | 10% Owner | C Conversion deriv | 2022-05-10 | 2022-05-10 | 1,285,720 | — | $0 | 0 | SEC↗ |
| Oxford Science Enterprises plc | 10% Owner | C Conversion deriv | 2022-05-10 | 2022-05-10 | 1,575,572 | — | $0 | 0 | SEC↗ |
| Oxford Science Enterprises plc | 10% Owner | C Conversion deriv | 2022-05-10 | 2022-05-10 | 962,884 | — | $0 | 0 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | C Conversion deriv | 2022-05-10 | 2022-05-12 | 646,306 | — | $0 | 0 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | C Conversion deriv | 2022-05-10 | 2022-05-12 | 2,199,741 | — | $0 | 0 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | C Conversion deriv | 2022-05-10 | 2022-05-12 | 425,497 | — | $0 | 0 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | C Conversion deriv | 2022-05-10 | 2022-05-12 | 211,410 | — | $0 | 0 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | C Conversion deriv | 2022-05-10 | 2022-05-12 | 1,508,048 | — | $0 | 0 | SEC↗ |
| Deerfield Private Design Fund | 10% Owner | P Buy | 2022-05-10 | 2022-05-10 | 208,333 | $12.00 | $2.50M | 476,813 | SEC↗ |
| Deerfield Private Design Fund | 10% Owner | P Buy | 2022-05-10 | 2022-05-10 | 208,333 | $12.00 | $2.50M | 476,813 | SEC↗ |
| Deerfield Private Design Fund | 10% Owner | C Conversion | 2022-05-10 | 2022-05-10 | 268,480 | — | $0 | 268,480 | SEC↗ |
| Deerfield Private Design Fund | 10% Owner | C Conversion | 2022-05-10 | 2022-05-10 | 268,480 | — | $0 | 268,480 | SEC↗ |
| Oxford Science Enterprises plc | 10% Owner | C Conversion | 2022-05-10 | 2022-05-10 | 945,859 | — | $0 | 2,327,705 | SEC↗ |
| Oxford Science Enterprises plc | 10% Owner | C Conversion | 2022-05-10 | 2022-05-10 | 1,547,713 | — | $0 | 3,875,418 | SEC↗ |
| Oxford Science Enterprises plc | 10% Owner | C Conversion | 2022-05-10 | 2022-05-10 | 1,262,986 | — | $0 | 1,381,846 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | C Conversion | 2022-05-10 | 2022-05-12 | 3,642,229 | — | $0 | 3,642,229 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | P Buy | 2022-05-10 | 2022-05-12 | 249,749 | $12.00 | $3.00M | 1,302,600 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | C Conversion | 2022-05-10 | 2022-05-12 | 207,672 | — | $0 | 207,672 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | C Conversion | 2022-05-10 | 2022-05-12 | 1,052,851 | — | $0 | 1,052,851 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | P Buy | 2022-05-10 | 2022-05-12 | 2,979,451 | $12.00 | $35.75M | 6,621,680 | SEC↗ |
| KEATING LAURIE | Director | P Buy | 2022-05-06 | 2023-01-19 | 4,166 | $12.00 | $50.0K | 4,166 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | A Award deriv | 2022-05-06 | 2022-05-10 | 11,667 | — | $0 | 11,667 | SEC↗ |
| Ashton Christopher | Director | A Award deriv | 2022-05-06 | 2022-05-10 | 11,667 | — | $0 | 11,667 | SEC↗ |
| Bracegirdle Sonia | See Remarks | A Award deriv | 2022-05-06 | 2022-05-10 | 79,547 | — | $0 | 79,547 | SEC↗ |
| Donnelly Noel | Chief Financial Officer | A Award deriv | 2022-05-06 | 2022-05-10 | 169,037 | — | $0 | 169,037 | SEC↗ |
| Goyal Jaya | See Remarks | A Award deriv | 2022-05-06 | 2022-05-10 | 79,920 | — | $0 | 79,920 | SEC↗ |
| HENSON HEIDI | Director | A Award deriv | 2022-05-06 | 2022-05-10 | 11,667 | — | $0 | 11,667 | SEC↗ |
| KEATING LAURIE | Director | A Award deriv | 2022-05-06 | 2022-05-10 | 5,833 | — | $0 | 5,833 | SEC↗ |
| McArthur James G | President and CEO | A Award deriv | 2022-05-06 | 2022-05-10 | 466,095 | — | $0 | 466,095 | SEC↗ |
| Mellion Michelle L | See Remarks | A Award deriv | 2022-05-06 | 2022-05-10 | 16,655 | — | $0 | 16,655 | SEC↗ |
| Resnick Joshua | Director | A Award deriv | 2022-05-06 | 2022-05-10 | 11,667 | — | $0 | 11,667 | SEC↗ |
| Svenstrup Niels | See Remarks | A Award deriv | 2022-05-06 | 2022-05-10 | 109,874 | — | $0 | 109,874 | SEC↗ |